EDUCATIONAL OBJECTIVES Upon completion of this Performance in Practice, the participant will be able to:
- Improve the quality of healthcare they provide.
- Adopt a self-directed assessment process.
- Apply best practices in diagnosing and treating carpal tunnel syndrome.
STAGE 1:
Preimplementation Chart Review
- Review at least 5 patient charts from the physician’s practice.
- Charts should be for patients diagnosed with carpal tunnel syndrome within the previous 3 years.
- Use the Diagnostic Pre-Chart Review checklist and its criteria to guide and document the review.
Performance Improvement Goal
- Develop a performance improvement goal after completing the initial chart review.
- Identify criteria to address during the implementation period.
- Consider barriers, opportunities for improvement, and ways to improve practice effectiveness and/or efficiency.
- Record the goal on the Diagnostic Pre-Chart Review checklist.
STAGE 2:
Toolkit Review
- Review the educational toolkit after establishing the performance improvement goal.
- Use the toolkit to help identify ways to meet the improvement goal.
- Toolkit resources include:
- Practice Parameter for Electrodiagnostic Studies in Carpal Tunnel Syndrome: Summary Statement
- Second AAEM Literature Review on Nerve Conduction Studies and Needle EMG for Carpal Tunnel Syndrome
- Clinical Quality Measures for Electrodiagnosis in Suspected Carpal Tunnel Syndrome
- Evidence-based Guideline: Neuromuscular Ultrasound for the Diagnosis of Carpal Tunnel Syndrome
Implementation Period
- Work to modify practice behavior based on the performance improvement goal.
- Implementation must last at least 30 days and should not exceed 2 years.
- The 30-day period begins after all Step 2 toolkit documents have been viewed.
STAGE 3:
Post--implementation Chart Review
- Review at least 5 additional charts from patients diagnosed with carpal tunnel syndrome.
- Use the Diagnostic Post-Chart Review checklist and criteria to evaluate and document the review.
Clinical Outcome Summary
- Compare the preimplementation and postimplementation chart review results.
- Write a narrative summary describing the PIP results in relation to the original goal.
- The summary may include data analysis, barriers to implementation, impact on patient care, and/or impact on communication with the referring physician.
SETUPThe PIP implementation period (Stage 2)
must be at least
30 days in duration and not exceed 2 years. AANEM PIPs include both a Clinical and Feedback Module; only the Clinical Module is designated for CME. Each module is structured into three stages: 1) An initial review of performance; 2) a performance improvement implementation period; and 3) a reassessment of performance. The AANEM will report PIP completion to ABPN and ABPMR on your behalf.
ACCREDITATION STATEMENT
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
CREDIT DESIGNATION
The AANEM designates this Performance Improvement Continuing Medical Education (PI CME) activity for a maximum of 20 AMA PRA Category 1 Credit(s).TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planners and authors for this course had no disclosures.
Quality Improvement Committee
Elizabeth J. Angus, MD- no disclosures
Michele L. Arnold, MD- no disclosures
Lorna A. Brock, CNCT, R.NCS.T- no disclosures
Mohammad A. Choudhry, MD- no disclosures
David R. Del Toro, MD- no disclosures
Segun T. Dawodu, MD, JD, MBA, LL.M, MS- no disclosures
Nida G. Gleveckas-Martens, DO- no disclosures
Ana M. Hess, CNCT, R.NCS.T- no disclosures
Lyell K. Jones, MD- no disclosures
Nanette C. Joyce, DO- no disclosures
Charles D. Kassardjian, MD- no disclosures
John C. Kincaid, MD- no disclosures
Kerry H. Levin, MD- no disclosures
Michelle A. McFarlane, MD- no disclosures
Pushpa Narayanaswami, MBBS, DM, FAAN- (Committee Chair)- no disclosures
Kenkichi Nozaki, MD, PhD- no disclosures
David B. Rosenfield, MD- no disclosures
Renee A. Schwarz, CNCT, R. NCST., R. EEG T., R. EP T.,C.M.E.T.- no disclosures
Dan Y. Shamir, MD- no disclosures
Michael D. Stubblefield, MD- no disclosures
Sasha Zivkovic, MD- no disclosures
Carrie Winter (staff)- no disclosures
THE AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY HAS REVIEWED THE PERFORMANCE IN PRACTICE: CARPAL TUNNEL SYNDROME AND HAS APPROVED THIS ACTIVITY AS PART OF A COMPREHENSIVE IMPROVEMENT IN MEDICAL PRACTICE (PIP) ACTIVITY, WHICH IS MANDATED BY THE ABMS AS A NECESSARY COMPONENT OF CONTINUING CERTIFICATION.
The American Board of Physical Medicine & Rehabilitation has approved this activity for QI/IHHC credit.